News
‘Frame running’ may help boost physical activity in MS
- Author:
- Liam Davenport
‘Frame running’ uses a three-wheeled frame with a saddle and body supports but no pedals to allow individuals with disabilities and balance...
News
Recombinant IL-2 shows potential in atopic dermatitis
- Author:
- Liam Davenport
Rezpegaldesleukin is now being evaluated in a phase 2b study for moderate to severe atopic dermatitis, and a phase 2b trial for alopecia areata is...
News
Chemo-immunotherapy good, adding a PARP inhibitor better in endometrial cancer?
- Author:
- Liam Davenport
Dr. Tan noted, the AtTEnd data "continue to validate practice-changing therapy for dMMR endometrial cancer patients."
News
Wearable devices show promise in monitoring multiple sclerosis
- Author:
- Liam Davenport
Further analysis may allow the prediction of “relevant changes throughout the course of multiple sclerosis.”
News
Can some patients with esophageal cancer avoid surgery?
- Author:
- Liam Davenport
About one-third of patients with esophageal cancer who have a compete response to neoadjuvant chemoradiotherapy may be able to avoid surgery....
News
Smart bracelet may predict mood changes in bipolar disorder
- Author:
- Liam Davenport
Each sensor collects a sample every second, resulting in highly detailed and granular data.
News
MS-tailored weight loss program achieves meaningful results
- Author:
- Liam Davenport
Weight loss “was associated with improved mobility, reduced fatigability, and improved physical quality of life.”
News
AI tool reveals MS drug interactions, offers safer options
- Author:
- Liam Davenport
Deep learning–based methods are “useful” in screening for potential interactions both between drugs and with foods.
News
Ocrelizumab benefit confirmed in older patients with MS
- Author:
- Liam Davenport
Lower rates of relapse were seen in older patients taking ocrelizumab, but the risk for relapse in this age group is low.
News
Confirmed: Intermittent use of benzodiazepines is the safest option
- Author:
- Liam Davenport
“We’ve always known that there was a problem, but there haven’t been high-quality epidemiological studies like this that allowed us to say what...
News
Esketamine bests quetiapine for severe depression in head-to-head trial
- Author:
- Liam Davenport
“These patients are not resistant, they just have resistance to monoaminergic drugs.”
News
Running vs. meds for depression: Is there a clear winner?
- Author:
- Liam Davenport
Medication “generally had worse impact on body weight, heart rate variability, and blood pressure, whereas running therapy led to improved effect...
News
Exercise timing may dictate obesity, type 2 diabetes risk
- Author:
- Liam Davenport
People who exercised in the morning had a lower body mass index than those who exercised at other times, even though they were more sedentary.
News
Many patients with NSCLC receive immunotherapy ‘indefinitely’ – Are they benefiting?
- Author:
- Liam Davenport
Without “incontrovertible evidence” that immunotherapy should stop at 2 years, “many, many, many patients and clinicians are going to favor...
News
Proposed TNM update could shift staging for lung cancers
- Author:
- Liam Davenport
Lung cancers, particularly those with T1 disease, could be reclassified into a different overall stage if proposed adaptations to the N and M...